baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Merck & Co Inc/ US58933Y1055 /

29/05/2024 16:39:51	Chg. -0.35	Volume	Bid16:40:34	Ask16:40:26	Market Capitalization	Dividend Y.	P/E Ratio
125.79USD	-0.28%	47,951 Turnover: 3.09 mill.	125.74Bid Size: 1	125.83Ask Size: 2	318.63 bill.USD	2.35%	898.57

TeleTrader 13:37 Merck to buy biotech firm EyeBio for up to $3B

GlobeNewswire 13:02 Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio fo...

GlobeNewswire 08:00 Anaveon announces IND approval of ANV600-001 (EXPAND) Phase I/II clinical study

GlobeNewswire 07/05 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...

GlobeNewswire 06/05 Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...

GlobeNewswire 02/05 Cerevance Achieves First Milestone in Research Collaboration with Merck

TeleTrader 25/04 Merck's Q1 sales rise by 9% to $15.8 billion

GlobeNewswire 02/04 Vaccinex Reports 2023 Financial Results and Provides Corporate Update

GlobeNewswire 06/03 IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Can...

GlobeNewswire 04/03 C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...

TeleTrader 02/02 Merck Group to expand investment in South Korea

TeleTrader 01/02 Merck's Q4 sales up 6% to $14.6B

TeleTrader 27/01 J&J, Merck CEOs to testify before Senate on drug prices

GlobeNewswire 23/01 Unnatural Products, Inc. Enters Research Collaboration with Merck

GlobeNewswire 21/12/2023 Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...

GlobeNewswire 19/12/2023 Unnatural Products, Inc. Announces $32 Million in Series A Funding Led by Merck Global Health Innova...

GlobeNewswire 14/12/2023 ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...

GlobeNewswire 12/12/2023 C4 Therapeutics Announces License and Research Collaboration with Merck to Discover and Develop Degr...

GlobeNewswire 05/12/2023 HiberCell, Inc. Announces Clinical Collaboration with Merck to Evaluate HC-7366, an Activator of ISR...

GlobeNewswire 04/12/2023 Nasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain Compliance with Listing Rule

GlobeNewswire 13/11/2023 Vaccinex Reports Third Quarter 2023 Financial Results and Provides Corporate Update

TeleTrader 26/10/2023 Merck's Q3 sales up 7% to $16B

TeleTrader 20/10/2023 Daiichi Sankyo, Merck announce collaboration on cancer drugs

GlobeNewswire 17/10/2023 ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA

GlobeNewswire 28/09/2023 Merck KGaA, Darmstadt, Germany and Quris-AI Expand Collaboration

Merck & Co Inc/ US58933Y1055 /

If you wish to receive reply to your feedback, please provide your email address.